Victory Capital Management Inc. Boosts Stake in Surgery Partners, Inc. (NASDAQ:SGRY)

Victory Capital Management Inc. grew its position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 140.4% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,330,399 shares of the company's stock after buying an additional 777,038 shares during the period. Victory Capital Management Inc. owned 1.05% of Surgery Partners worth $42,892,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Quarry LP boosted its stake in Surgery Partners by 133.1% in the second quarter. Quarry LP now owns 3,082 shares of the company's stock valued at $73,000 after acquiring an additional 1,760 shares in the last quarter. DekaBank Deutsche Girozentrale grew its stake in Surgery Partners by 102.0% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company's stock worth $80,000 after buying an additional 1,375 shares during the last quarter. EntryPoint Capital LLC raised its stake in Surgery Partners by 257.1% in the first quarter. EntryPoint Capital LLC now owns 6,399 shares of the company's stock valued at $191,000 after buying an additional 4,607 shares during the last quarter. Creative Planning purchased a new stake in Surgery Partners in the third quarter valued at about $258,000. Finally, Versor Investments LP purchased a new stake in shares of Surgery Partners during the third quarter worth about $271,000.

Surgery Partners Stock Performance

SGRY traded down $1.82 during midday trading on Friday, hitting $22.95. 1,227,937 shares of the company were exchanged, compared to its average volume of 950,542. The firm has a market capitalization of $2.92 billion, a price-to-earnings ratio of -47.81, a price-to-earnings-growth ratio of 18.74 and a beta of 2.76. The company's 50 day simple moving average is $30.62 and its 200 day simple moving average is $28.45. The company has a current ratio of 1.80, a quick ratio of 1.69 and a debt-to-equity ratio of 0.99. Surgery Partners, Inc. has a 1-year low of $22.25 and a 1-year high of $36.92.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its earnings results on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The company had revenue of $770.40 million for the quarter, compared to analyst estimates of $768.99 million. During the same period last year, the business earned $0.15 earnings per share. The firm's revenue was up 14.3% on a year-over-year basis. As a group, sell-side analysts predict that Surgery Partners, Inc. will post 0.83 earnings per share for the current year.

Analysts Set New Price Targets

SGRY has been the subject of several research analyst reports. KeyCorp initiated coverage on shares of Surgery Partners in a research report on Friday, October 11th. They issued a "sector weight" rating for the company. UBS Group began coverage on shares of Surgery Partners in a report on Monday, October 14th. They set a "buy" rating and a $38.00 price objective on the stock. Royal Bank of Canada reissued an "outperform" rating and issued a $49.00 target price on shares of Surgery Partners in a research report on Wednesday, August 7th. Benchmark reaffirmed a "buy" rating and set a $50.00 price target on shares of Surgery Partners in a research report on Monday, August 26th. Finally, StockNews.com lowered Surgery Partners from a "hold" rating to a "sell" rating in a report on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $40.71.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.